This half-day benchmarking event provides an intimate setting for lawyers and compliance officers to engage in an interactive dialogue on the following topics:
- From 2015 to 2025: A 10-year Overview of China’s Life Sciences Regulations — What’s Happened and What’s Next
- What “Sanctions” Mean: International Trade Compliance for Pharmaceutical and Medical Device Companies
- U.S. Outbound Investment Rules and America First Investment Policy: Impacts on Chinese Biotechs
- An introduction to the U.S. FDA Guidance for Use of AI in Drug Developments
- Compliance Essentials for Life Sciences Companies in Hong Kong
Speakers
- Chen Yang, Senior Counsel, Sidley
- Lei Li, Partner, Sidley
- Ruchun Ji, Partner, Sidley
- Shu Min Ho, Partner, Sidley
Should you have any questions, please contact sidleychinalifesciencesroundtable@sidley.com.
